Drug–drug interaction profile of components of a fixed combination of netupitant and palonosetron: Review of clinical data

Neurokinin-1 (NK(1)) receptor antagonists (RAs) are commonly coadministered with serotonin (5-HT(3)) RAs (e.g. palonosetron (PALO)) to prevent chemotherapy-induced nausea/vomiting. Netupitant/palonosetron (NEPA), an oral fixed combination of netupitant (NETU)—a new NK(1) RA—and PALO, is currently un...

Descripción completa

Detalles Bibliográficos
Autores principales: Natale, James J, Spinelli, Tulla, Calcagnile, Selma, Lanzarotti, Corinna, Rossi, Giorgia, Cox, David, Kashef, Kimia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843089/
https://www.ncbi.nlm.nih.gov/pubmed/25998320
http://dx.doi.org/10.1177/1078155215586824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843089/
https://www.ncbi.nlm.nih.gov/pubmed/25998320
http://dx.doi.org/10.1177/1078155215586824

Ejemplares similares